Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Journal of Geriatric Oncology|November 6, 2019
Effects of chemotherapy on aging white matter microstructure: A longitudinal diffusion tensor imaging studyBihong T Chen, Ningrong Ye, Chi Wah Wong, et al.
Clinical Breast Cancer|December 4, 2018
A Phase II Trial of Older Adults With Metastatic Breast Cancer Receiving nab-Paclitaxel: Melding the Fields of Geriatrics and OncologyArti Hurria, Enrique Soto-Perez-de-Celis, Suzette Blanchard, et al.
The Oncologist|April 12, 2026
Phase 2 Study of Cabozantinib (XL184) with Nivolumab and Ipilimumab for the Treatment of Poorly Differentiated Neuroendocrine Carcinomas (ETCTN10315)Adel Mandl, Ruizhe Chen, Satya Das, et al.
Breast Cancer Research and Treatment|August 9, 2018
Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancerBihong T Chen, Taihao Jin, Sunita K Patel, et al.
Breast Cancer Research : BCR|May 4, 2018
Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot studyBihong T Chen, Sean K Sethi, Taihao Jin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 21, 2022
Diet quality indices and changes in cognition during chemotherapySylvia L Crowder, Taylor L Welniak, Aasha I Hoogland, et al.
Magnetic Resonance Imaging|August 5, 2018
Subcortical brain iron deposition and cognitive performance in older women with breast cancer receiving adjuvant chemotherapy: A pilot MRI studyBihong T Chen, Kiarash Ghassaban, Taihao Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2026
Multi-center Phase 1 study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388)Aman Chauhan, Heidi L Weiss, Charles Kunos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancerThatcher Ross Heumann, Jiayun Lu, Hao Wang, et al.
Cancer|October 13, 2021
Metagenomics and chemotherapy-induced nausea: A roadmap for future researchSylvia L Crowder, Aasha I Hoogland, Taylor L Welniak, et al.
Pageof 11